San Diego biotech to work with J&J unit on diabetes drugs

12/23/2004 | San Diego Union-Tribune

Arena Pharmaceuticals said it and Johnson & Johnson's Ortho-McNeil Pharmaceutical division will collaborate on type 2 diabetes drugs, based on Arena's compounds still in the early lab testing phase. The $17.5 million Ortho-McNeil is to pay up front is considered a high price for an experimental compound, and that payment is to be followed by another $4.8 million in research funds over a two-year period.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC